stilbenes and Glomerulosclerosis--Focal-Segmental

Focal segmental glomerulosclerosis (FSGS) typically presents with nephrotic range proteinuria, which could eventually develop into end-stage renal disease. Resveratrol (RSV) is a natural polyphenol compound, which has been reported to suppress inflammatory response and renal interstitial fibrosis. This study is aimed at evaluating the renoprotective effect of RSV treatment on adriamycin-induced FSGS.. In Balb/c mice, adriamycin nephropathy was induced by adriamycin (10 mg/kg body weight, diluted in normal saline) via a tail vein on day 0. Then the mice were treated with RSV (40 mg/kg body weight) once daily by oral gavage, again starting on the day of adriamycin injection and continued for 6 weeks. At 6 weeks, the mice were sacrificed; kidneys and blood samples were collected for further analysis.. When treated with adriamycin, the expressions of C3aR, C5aR, sphingosine kinase 1 (Sphk1), and soluble urokinase-type plasminogen activator receptor (suPAR) were upregulated, while RSV treatment could inhibit the expressions of C3aR, C5aR, Sphk1, and suPAR, eventually leading to anti-inflammatory and anti-fibrosis conditions.. RSV attenuates adriamycin-induced FSGS through C3aR/C5aR-Sphk1 pathway.

Topics: Animals; Anti-Inflammatory Agents; Doxorubicin; Fibrosis; Glomerulosclerosis, Focal Segmental; Kidney; Male; Mice; Mice, Inbred BALB C; Phosphotransferases (Alcohol Group Acceptor); Receptor, Anaphylatoxin C5a; Receptors, G-Protein-Coupled; Resveratrol; Signal Transduction; Stilbenes